Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomicin exerts its pharmacological effects primarily through the inhibition of bacterial RNA polymerase and is frequently prescribed for the treatment of diarrheal episodes att···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：449
DIFICID is a medication used to treat Clostridium difficile associated diarrhea, and its use in specific populations requires particular caution.Use in Specific Populations?For cer···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：376
Fidaxomicin is a prescription medication that should be administered under the guidance of a physician. Patients are advised to undergo regular examinations, observe any discomfort···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：344
Adlumiz is a novel oral pharmaceutical agent utilized primarily in the management of weight and muscle wasting resulting from malignancies. A plethora of clinical trials have corro···【more】
Article source：Captain MedicineRelease date：2024-08-05Recommended：407
Fidaxomicin is a pharmacological agent specifically indicated for the treatment of Clostridium difficile associated diarrhea, suitable for adult and pediatric patients aged 6 month···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：452
Fidaxomicin is primarily employed for the management of Clostridium difficile-associated diarrhea (CDAD). This medication exhibits low systemic absorption, lacks efficacy against d···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：462
Anamorelinis a medication utilized in the treatment of specific ailments, and like all medications, Anamorelinmay potentially elicit some adverse effects. Patients should be well i···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：355
Fidaxomicin is a pharmaceutical for the treatment of difficile-associated diarrhea (CDAD), indicated for adult and pediatric patients aged 6 months and older. CDAD is a gastrointes···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：465
fidaxomicin, a pharmacological agent renowned for its efficacy against Clostridium difficile infection, operates by impeding the metabolic pathways of the bacterium, thus inhibitin···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：443
Fidaxomicin is a pharmaceutical agent specifically designed to combat infections caused by Clostridium difficile. Prior to initiating treatment with Fidaxomicin, patients are advis···【more】
Article source：Captain MedicineRelease date：2024-07-30Recommended：387
Sotorasib, a targeted therapeutic agent for advanced non-small cell lung cancer (NSCLC) patients harboring the KRAS G12C mutation, exerts its efficacy by specifically inhibiting th···【more】
Article source：Captain MedicineRelease date：2024-07-09Recommended：503
Sotorasib, also known as Lumakras, is a targeted drug designed for patients with NSCLC carrying the KRAS G12C gene mutation. This medication inhibits the activity of the KRAS G12C ···【more】
Article source：Captain MedicineRelease date：2024-07-09Recommended：494
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
